Clinical Trial Update: Naltrexone and Bupropion Combination on Obese,Smoking Patients With Schizophrenia [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating a naltrexone and bupropion combination in obese, cigarette-smoking individuals with schizophrenia has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cigarette Smoking
• Obesity
• Schizophrenia

Drugs mentioned

• Naltrexone and bupropion combination

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Obese, Cigarette-smoking | Phase 4 | Status: COMPLETED | Results posted: 2021-10-22